Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MAYNF

Mayne Pharma Group Limited

USD

Set alert

Price alert · MAYNF

All alert types
1.87 USD 0.00 0.00%
As of Oct 30, 2026
1.85 Day range 1.85
1.40 52-week range 4.00
YTD
-9.66%
1 year
-53.25%
Open
1.85
Prev close
1.87
Mkt cap
153.14M
Vol
3.10K
Avg vol
1.44K
EPS
0.21
P/E
8.90
More statistics
Low
1.85
High
1.85

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for MAYNF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.99 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 3
  • P/E 4
  • P/B 5

Valuation

P/E 7.9×
FY 2017: 0.9×FY 2018: -0.5×FY 2019: -0.1×FY 2020: -0.3×FY 2021: -0.1×FY 2022: -0.1×FY 2023: -1.0×FY 2024: -2.1×FY 2025: -4.4×FY 2026: 7.9×
FY 2017 5y median -1.0× FY 2026
P/S 0.5×
FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 1.7×FY 2024: 0.9×FY 2025: 1.0×FY 2026: 0.5×
FY 2017 5y median 0.9× FY 2026
P/B 0.5×
FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.5×FY 2024: 0.8×FY 2025: 1.1×FY 2026: 0.5×
FY 2017 5y median 0.5× FY 2026
P/FCF 15.1×
FY 2017: -0.1×FY 2018: 2.3×FY 2019: 1.5×FY 2020: 0.5×FY 2021: 1.2×FY 2022: -0.7×FY 2023: -1.2×FY 2024: -9.9×FY 2025: 77.1×FY 2026: 15.1×
FY 2017 5y median -0.7× FY 2026
EV/EBITDA 5.2×
FY 2017: 1.8×FY 2018: 2.9×FY 2019: 2.9×FY 2020: 3.3×FY 2021: 5.1×FY 2022: -8.1×FY 2023: -1.5×FY 2024: -3.6×FY 2025: 7.5×FY 2026: 5.2×
FY 2017 5y median -1.5× FY 2026
EV/Sales 0.4×
FY 2017: 0.6×FY 2018: 0.7×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.7×FY 2022: 2.1×FY 2023: 1.4×FY 2024: 0.8×FY 2025: 0.9×FY 2026: 0.4×
FY 2017 5y median 0.9× FY 2026
FCF Yield 6.6%
FY 2017: -1357.2%FY 2018: 43.7%FY 2019: 65.7%FY 2020: 190.2%FY 2021: 85.3%FY 2022: -153.1%FY 2023: -82.9%FY 2024: -10.1%FY 2025: 1.3%FY 2026: 6.6%
FY 2017 5y median -10.1% FY 2026

Profitability

Gross Margin 50.1%
FY 2017: 55.1%FY 2018: 49.7%FY 2019: 57.5%FY 2020: 49.3%FY 2021: 48.6%FY 2022: 108.3%FY 2023: 14.6%FY 2024: 56.3%FY 2025: 60.6%FY 2026: 50.1%
FY 2017 5y median 56.3% FY 2026
Operating Margin -8.9%
FY 2017: 25.8%FY 2018: 7.7%FY 2019: 2.9%FY 2020: 0.8%FY 2021: -9.1%FY 2022: -86.3%FY 2023: -101.6%FY 2024: -35.8%FY 2025: -5.8%FY 2026: -8.9%
FY 2017 5y median -35.8% FY 2026
Net Margin 6.4%
FY 2017: 15.5%FY 2018: -25.3%FY 2019: -53.6%FY 2020: -20.3%FY 2021: -52.1%FY 2022: -133.3%FY 2023: 63.9%FY 2024: -44.9%FY 2025: -23.0%FY 2026: 6.4%
FY 2017 5y median -23.0% FY 2026
ROE 6.3%
FY 2017: 6.8%FY 2018: -10.9%FY 2019: -27.9%FY 2020: -8.9%FY 2021: -27.1%FY 2022: -37.1%FY 2023: 18.5%FY 2024: -38.4%FY 2025: -25.3%FY 2026: 6.3%
FY 2017 5y median -25.3% FY 2026
ROIC -4.3%
FY 2017: 6.3%FY 2018: 2.0%FY 2019: 0.8%FY 2020: 0.1%FY 2021: -2.2%FY 2022: -12.5%FY 2023: -19.6%FY 2024: -14.3%FY 2025: -3.0%FY 2026: -4.3%
FY 2017 5y median -12.5% FY 2026
ROA 2.7%
FY 2017: 4.6%FY 2018: -7.3%FY 2019: -17.2%FY 2020: -5.1%FY 2021: -14.2%FY 2022: -16.3%FY 2023: 9.4%FY 2024: -15.2%FY 2025: -9.2%FY 2026: 2.7%
FY 2017 5y median -9.2% FY 2026

Growth (YoY)

Revenue -6.1%
FY 2017: 114.8%FY 2018: -7.5%FY 2019: -1.0%FY 2020: -12.9%FY 2021: -12.3%FY 2022: -60.7%FY 2023: 16.8%FY 2024: 111.4%FY 2025: 5.1%FY 2026: -6.1%
FY 2017 FY 2026
Operating Income -45.1%
FY 2017: 182.4%FY 2018: -72.5%FY 2019: -62.0%FY 2020: -77.4%FY 2021: -1144.5%FY 2022: -271.5%FY 2023: -37.5%FY 2024: 25.4%FY 2025: 83.0%FY 2026: -45.1%
FY 2017 FY 2026
EPS (diluted) 117.5%
FY 2017: 31.5%FY 2018: -251.2%FY 2019: -108.2%FY 2020: 68.2%FY 2021: -119.0%FY 2022: -20.8%FY 2023: -14.7%FY 2024: 42.2%FY 2025: 46.2%FY 2026: 117.5%
FY 2017 FY 2026
Free Cash Flow 143.7%
FY 2017: -11663.3%FY 2018: 102.5%FY 2019: -9.1%FY 2020: 113.3%FY 2021: -57.9%FY 2022: -228.5%FY 2023: -822.7%FY 2024: 86.2%FY 2025: 114.4%FY 2026: 143.7%
FY 2017 FY 2026

Financial Health

Current Ratio 1.3×
FY 2017: 2.1×FY 2018: 2.7×FY 2019: 2.2×FY 2020: 2.2×FY 2021: 1.9×FY 2022: 0.8×FY 2023: 1.8×FY 2024: 1.5×FY 2025: 1.4×FY 2026: 1.3×
FY 2017 5y median 1.4× FY 2026
Quick Ratio 1.1×
FY 2017: 1.6×FY 2018: 2.2×FY 2019: 1.8×FY 2020: 1.8×FY 2021: 1.4×FY 2022: 0.7×FY 2023: 1.5×FY 2024: 1.2×FY 2025: 1.2×FY 2026: 1.1×
FY 2017 5y median 1.2× FY 2026
Debt / Equity 0.1×
FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 0.5×FY 2022: 0.7×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.1×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -1.3×
FY 2017: 1.4×FY 2018: 2.4×FY 2019: 2.6×FY 2020: 3.0×FY 2021: 4.6×FY 2022: -7.6×FY 2023: 0.3×FY 2024: 0.4×FY 2025: -0.4×FY 2026: -1.3×
FY 2017 5y median -0.4× FY 2026
Interest Coverage -6.5×
FY 2017: 12.9×FY 2018: 2.4×FY 2019: 0.9×FY 2020: 0.1×FY 2021: -1.1×FY 2022: -4.2×FY 2023: -17.8×FY 2024: -4.0×FY 2025: -0.7×FY 2026: -6.5×
FY 2017 5y median -4.2× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 333.9%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 14.3%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 305.3%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 38.6%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30